Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.

Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant. Mov Disord. 2013 Nov; 28(13):1905-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.